Evidence map›Paper›PMID 35269267›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Composition-Dependent Cytotoxic and Antibacterial Activity of Biopolymer-Capped Ag/Au Bimetallic Nanoparticles against Melanoma and Multidrug-Resistant Pathogens.

Alfonso Nieto-Argüello, David Medina-Cruz, Yeremi S Pérez-Ramírez, Sergio A Pérez-García, Miguel A Velasco-Soto, Zeinab Jafari, Israel De Leon, María Ujué González, Yves Huttel, Lidia Martínez and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Green biosynthesis of bimetallic selenium-gold nanoparticles usingFrontiers in bioengineering and biotechnology · 2023
    Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Alfonso Nieto-ArgüelloSchool of Engineering and Sciences, Tecnologico de Monterrey, Eugenio Garza Sada 2501, Monterrey 64849, NL, Mexico.ORCID 0000-0002-2460-1324
David Medina-CruzDepartment of Chemical Engineering, Northeastern University, Boston, MA 02115, USA.
Yeremi S Pérez-RamírezSchool of Engineering and Sciences, Tecnologico de Monterrey, Eugenio Garza Sada 2501, Monterrey 64849, NL, Mexico.ORCID 0000-0002-1487-605X
Sergio A Pérez-GarcíaCentro de Investigación en Materiales Avanzados, S. C. (CIMAV), Unidad Monterrey, Alianza Norte 202, Apodaca 66628, NL, Mexico.ORCID 0000-0002-6947-4728
Miguel A Velasco-SotoSchool of Engineering and Sciences, Tecnologico de Monterrey, Eugenio Garza Sada 2501, Monterrey 64849, NL, Mexico.
Zeinab JafariSchool of Engineering and Sciences, Tecnologico de Monterrey, Eugenio Garza Sada 2501, Monterrey 64849, NL, Mexico.
Israel De LeonSchool of Engineering and Sciences, Tecnologico de Monterrey, Eugenio Garza Sada 2501, Monterrey 64849, NL, Mexico.
María Ujué GonzálezInstituto de Micro y Nanotecnología, IMN-CNM, CSIC (CEI UAM+CSIC), Isaac Newton 8, 28760 Tres Cantos, Spain.ORCID 0000-0001-7012-0049
Yves HuttelInstituto de Ciencia de Materiales de Madrid, ICMM-CSIC, Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain.ORCID 0000-0002-3683-9890
Lidia MartínezInstituto de Ciencia de Materiales de Madrid, ICMM-CSIC, Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain.ORCID 0000-0002-9370-2962
Álvaro MayoralInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Pedro Cerbuna, 50009 Zaragoza, Spain.ORCID 0000-0002-5229-2717
Thomas J WebsterDepartment of Chemical Engineering, Northeastern University, Boston, MA 02115, USA.
José M García-MartínInstituto de Micro y Nanotecnología, IMN-CNM, CSIC (CEI UAM+CSIC), Isaac Newton 8, 28760 Tres Cantos, Spain.ORCID 0000-0002-5908-8428
Jorge L Cholula-DíazSchool of Engineering and Sciences, Tecnologico de Monterrey, Eugenio Garza Sada 2501, Monterrey 64849, NL, Mexico.ORCID 0000-0002-4457-1572
Tecnológico de Monterrey · MXInstitute of Micro and Nanotechnology · ESInstituto de Ciencia de Materiales de Madrid · ESNortheastern University · USCentro de Investigación en Materiales Avanzados · MXUniversidad de Zaragoza · ES

Funding

European Union's Horizon 2020 research and innovation programme 823717- ESTEEM3Monterrey Institute of Technology and Higher Education LINKB20024National Natural Science Foundation of China NSFC- 21835002Regional Government of Aragon E13_20RSpanish Ministry of Science RYC2018-024561-ISpanish National Research Council LINKB20024
6 · The paper itself

Abstract

Nanostructured silver (Ag) and gold (Au) are widely known to be potent biocidal and cytotoxic agents as well as biocompatible nanomaterials. It has been recently reported that combining both metals in a specific chemical composition causes a significant enhancement in their antibacterial activity against antibiotic-resistant bacterial strains, as well as in their anticancer effects, while preserving cytocompatibility properties. In this work, Ag/Au bimetallic nanoparticles over a complete atomic chemical composition range were prepared at 10 at% through a green, highly reproducible, and simple approach using starch as a unique reducing and capping agent. The noble metal nanosystems were thoroughly characterized by different analytical techniques, including UV-visible and FT-IR spectroscopies, XRD, TEM/EDS, XPS and ICP-MS. Moreover, absorption spectra simulations for representative colloidal Ag/Au-NP samples were conducted using FDTD modelling. The antibacterial properties of the bimetallic nanoparticles were determined against multidrug-resistant

Indexed as

anticancer activityantimicrobial resistancebimetallic nanoparticlesgreen chemistrynanomedicine

Identifiers

PMID35269267
PMCPMC8912067
OpenAlexW4214729382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.